Hong Kong (HSI) Groei aandelen Pharmaceuticals & Biotech

Name: Financiële inzichten gebaseerd op S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Mar 14, 2026

Ontdek Hong Kong Pharmaceuticals & Biotech Groeiaandelen die op de HSI. Gesorteerd op voorspelde groei, hebben deze Pharmaceuticals & Biotech Stocks een hoger dan verwachte winst- of omzetgroei in vergelijking met andere bedrijven.

124 bedrijven

Bedrijf	Laatste prijs	7D Terugkeer	1 J Rendement	Marktkapitalisatie	Doel analisten	Waardering	Groei	Div Opbrengst
3696	HK$55.15	-0.6%	n/a	HK$31.5b	HK$77.53	75.0	123.9%	n/a
1952	HK$36.10	-1.7%	-29.5%	HK$12.8b	HK$56.76	13.2	117.7%	n/a
2228	HK$9.50	-5.6%	46.2%	HK$40.9b	HK$9.99	52.9	113.3%	n/a
1477	HK$7.04	1.6%	46.4%	HK$5.7b	HK$9.92	9.3	113.1%	n/a
570	HK$1.95	-0.5%	-2.5%	HK$9.8b	HK$1.90	0.4	100.8%	0.2%
460	HK$1.43	-2.7%	138.3%	HK$13.0b	HK$2.30	5.5	90.4%	1.6%
2616	HK$7.11	6.9%	92.7%	HK$10.5b	HK$13.14	45.5	85.7%	n/a
1548	HK$11.09	-3.0%	-11.3%	HK$24.2b	HK$21.80	676.7	84.5%	0%
2171	HK$15.46	42.2%	21.5%	HK$8.6b	HK$20.01	60.2	83.6%	n/a
6185	HK$33.46	-1.4%	-10.4%	HK$13.5b	HK$56.54	261.3	79.9%	0%
9606	HK$270.40	-14.3%	n/a	HK$24.4b	HK$440.71	9.9	73.8%	n/a
2480	HK$23.00	-5.3%	-7.6%	HK$4.6b	n/a	5.5	73.5%	n/a
2487	HK$5.00	6.4%	-10.7%	HK$1.8b	HK$13.21	6.4	72.1%	n/a
2591	HK$22.12	-8.5%	n/a	HK$10.1b	HK$34.60	157.7	68.2%	n/a
6996	HK$4.15	6.1%	33.0%	HK$2.8b	HK$4.67	29.4	67.4%	n/a
1877	HK$20.06	3.8%	38.5%	HK$32.2b	HK$32.06	7.3	66.2%	n/a
2595	HK$29.42	17.2%	n/a	HK$10.9b	HK$58.89	49.6	66.2%	n/a
2629	HK$14.20	-6.9%	n/a	HK$4.2b	HK$100.01	25.3	57.9%	n/a
2315	HK$54.25	-0.7%	298.3%	HK$35.5b	n/a	123.3	50.3%	n/a
2509	HK$17.81	2.6%	61.9%	HK$4.0b	HK$36.63	11.0	47.1%	n/a
2561	HK$31.08	-3.1%	n/a	HK$3.3b	HK$50.79	3419.0	46.4%	n/a
9926	HK$110.20	2.7%	53.1%	HK$101.5b	HK$174.42	35.6	44.2%	n/a
6990	HK$394.80	2.2%	58.2%	HK$92.1b	HK$536.92	54.0	42.5%	n/a
9887	HK$62.20	15.5%	n/a	HK$12.4b	HK$81.94	103.9	40.7%	n/a

Page 1 of 6